"Inflammatory Mechanisms May Underlie Increased Risk of Prostate Cancer Among World Trade Center Responders"
Researchers from the Icahn School of Medicine at Mount Sinai have found inflammatory and immune-regulatory mechanisms were found to be altered in animal models and in archived prostate cancer tumor samples of responders exposed to dust from the World Trade Center terrorist attacks on Sept. 11, 2001. Study author Emanuela Taioli, MD, PhD, professor of population health science and policy and thoracic surgery at the Icahn School of Medicine at Mount Sinai said, “World Trade Center responders show an overall increase in cancer incidence, including prostate cancer.” William Oh, MD, professor of medicine, hematology, urology, and medical oncology at the Icahn School of Medicine at Mount Sinai and study author said, “It has been recognized that inflammation may be an important consideration in prostate cancer progression.”
— William K. Oh, MD, Professor, Medicine, Hematology, Medical Oncology, Urology, Associate Director, Clinical Research, Tisch Cancer Institute, Chief, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai
— Emanuela Taioli, MD, PhD, Professor, Population Health Science and Policy, Thoracic Surgery, Director, Institute for Translational Epidemiology, Director, Center for the Study of Thoracic Diseases Outcomes, Director, Social Epidemiology, Associate Director, Population Science, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai